Trials / Recruiting
RecruitingNCT07169656
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 15,000 (estimated)
- Sponsor
- The First Affiliated Hospital of Zhengzhou University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200 hospitals in China. By comparing patient outcomes under different therapeutic regimens, it aims to provide high-quality evidence-based medical data to optimize CHB treatment strategies and follow-up protocols, ultimately contributing to the advancement of a functional cure for chronic hepatitis B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ETV,TDF,TAF,TMF | treated with entecavir (ETV), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), or tenofovir amibufenamide (TMF) |
| DRUG | Peginterferon α-2b injection | treated with Peginterferon α-2b injection |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2032-06-30
- Completion
- 2032-12-31
- First posted
- 2025-09-12
- Last updated
- 2025-09-12
Locations
162 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07169656. Inclusion in this directory is not an endorsement.